Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1964 2
1966 4
1967 3
1968 3
1969 5
1970 3
1971 5
1972 4
1973 6
1974 3
1975 5
1976 4
1977 7
1978 7
1979 18
1980 6
1981 4
1982 5
1983 12
1984 8
1985 7
1986 10
1987 7
1988 10
1989 7
1990 13
1991 11
1992 16
1993 22
1994 19
1995 10
1996 17
1997 3
1998 11
1999 11
2000 18
2001 25
2002 35
2003 41
2004 37
2005 57
2006 53
2007 39
2008 52
2009 71
2010 78
2011 78
2012 65
2013 71
2014 80
2015 80
2016 92
2017 83
2018 103
2019 132
2020 169
2021 207
2022 232
2023 243
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

2,230 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study.
Johnson ML, Cho BC, Luft A, Alatorre-Alexander J, Geater SL, Laktionov K, Kim SW, Ursol G, Hussein M, Lim FL, Yang CT, Araujo LH, Saito H, Reinmuth N, Shi X, Poole L, Peters S, Garon EB, Mok T; POSEIDON investigators. Johnson ML, et al. Among authors: hussein m. J Clin Oncol. 2023 Feb 20;41(6):1213-1227. doi: 10.1200/JCO.22.00975. Epub 2022 Nov 3. J Clin Oncol. 2023. PMID: 36327426 Free PMC article. Clinical Trial.
Hussein M, Molina MA, Berkhout B, Herrera-Carrillo E. Hussein M, et al. Int J Mol Sci. 2023 Jan 13;24(2):1563. doi: 10.3390/ijms24021563. Int J Mol Sci. 2023. PMID: 36675077 Free PMC article. Review.
Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study.
Cho BC, Abreu DR, Hussein M, Cobo M, Patel AJ, Secen N, Lee KH, Massuti B, Hiret S, Yang JCH, Barlesi F, Lee DH, Ares LP, Hsieh RW, Patil NS, Twomey P, Yang X, Meng R, Johnson ML. Cho BC, et al. Among authors: hussein m. Lancet Oncol. 2022 Jun;23(6):781-792. doi: 10.1016/S1470-2045(22)00226-1. Epub 2022 May 13. Lancet Oncol. 2022. PMID: 35576957 Clinical Trial.
Glycemic control in the critically ill: Less is more.
Alhatemi G, Aldiwani H, Alhatemi R, Hussein M, Mahdai S, Seyoum B. Alhatemi G, et al. Among authors: hussein m. Cleve Clin J Med. 2022 Apr 1;89(4):191-199. doi: 10.3949/ccjm.89a.20171. Cleve Clin J Med. 2022. PMID: 35365557 Free article. Review.
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.
Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, Xiao J, Hooper AT, Hamilton JD, Musser BJ, Rofail D, Hussein M, Im J, Atmodjo DY, Perry C, Pan C, Mahmood A, Hosain R, Davis JD, Turner KC, Baum A, Kyratsous CA, Kim Y, Cook A, Kampman W, Roque-Guerrero L, Acloque G, Aazami H, Cannon K, Simón-Campos JA, Bocchini JA, Kowal B, DiCioccio AT, Soo Y, Geba GP, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD; Trial Investigators. Weinreich DM, et al. Among authors: hussein m. N Engl J Med. 2021 Dec 2;385(23):e81. doi: 10.1056/NEJMoa2108163. Epub 2021 Sep 29. N Engl J Med. 2021. PMID: 34587383 Free PMC article. Clinical Trial.
Oral lichen planus: comparative efficacy and treatment costs-a systematic review.
Sandhu S, Klein BA, Al-Hadlaq M, Chirravur P, Bajonaid A, Xu Y, Intini R, Hussein M, Vacharotayangul P, Sroussi H, Treister N, Sonis S. Sandhu S, et al. Among authors: hussein m. BMC Oral Health. 2022 May 6;22(1):161. doi: 10.1186/s12903-022-02168-4. BMC Oral Health. 2022. PMID: 35524296 Free PMC article.
Maxillary Odontogenic Keratocyst.
Walsh M, Hussein MA, Carter M, Abdulrahman S. Walsh M, et al. Among authors: hussein ma. J Surg Case Rep. 2022 Apr 11;2022(4):rjac078. doi: 10.1093/jscr/rjac078. eCollection 2022 Apr. J Surg Case Rep. 2022. PMID: 35422993 Free PMC article.
Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial.
Cascone T, Kar G, Spicer JD, García-Campelo R, Weder W, Daniel DB, Spigel DR, Hussein M, Mazieres J, Oliveira J, Yau EH, Spira AI, Anagnostou V, Mager R, Hamid O, Cheng LY, Zheng Y, Blando J, Tan TH, Surace M, Rodriguez-Canales J, Gopalakrishnan V, Sellman BR, Grenga I, Soo-Hoo Y, Kumar R, McGrath L, Forde PM. Cascone T, et al. Among authors: hussein m. Cancer Discov. 2023 Nov 1;13(11):2394-2411. doi: 10.1158/2159-8290.CD-23-0436. Cancer Discov. 2023. PMID: 37707791 Free PMC article. Clinical Trial.
Telocytes in Cutaneous Biology: A Reappraisal.
Ahmed AM, Hussein MR. Ahmed AM, et al. Among authors: hussein mr. Actas Dermosifiliogr. 2023 Mar;114(3):T229-T239. doi: 10.1016/ Epub 2023 Jan 20. Actas Dermosifiliogr. 2023. PMID: 36690154 Free article. Review. English, Spanish.
2,230 results